Robeco Institutional Asset Management B.V. Immunocore Holdings PLC Transaction History
Robeco Institutional Asset Management B.V.
- $49.7 Billion
- Q3 2024
A detailed history of Robeco Institutional Asset Management B.V. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 8,324 shares of IMCR stock, worth $268,199. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,324
Previous 19,869
58.11%
Holding current value
$268,199
Previous $673,000
61.52%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IMCR
# of Institutions
141Shares Held
41.4MCall Options Held
197KPut Options Held
451K-
Wellington Management Group LLP Boston, MA7.05MShares$227 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.5MShares$209 Million0.12% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$157 Million2.42% of portfolio
-
Primecap Management CO Pasadena, CA2.47MShares$79.6 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.16MShares$69.5 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.41B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...